Clinical trials: Over Weight People
Obesity &Amp;Amp; Overweight, Elderly (People Aged 65 or More)
Evaluation of Oxygen Reserve Index (ORi) in Obese and Non-Obese Patients Over 65 Years Old
After obtaining ethical committee approval, this single-center, prospective, observational study included volunteer patients of both sexes, aged 65 years and older, with ASA II-III risk scores, who were scheduled for elective…
- Conditions
- Obesity &Amp;Amp; Overweight, Elderly (People Aged 65 or More), Oxygen Reserve Index
- Trial name
- NCT07679724
- Where
- Turkey (Türkiye)
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Ankara City Hospital Bilkent
Obesity
A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
The main objective of this trial is to investigate the effect of BI 1820237 alone, BI 456906 alone, combination of BI 1820237 and BI 456906 versus placebo on brain activity.
- Trial name
- NCT06352424
- Testing
- BI 456906, BI 1820237
- Where
- Germany
- Volunteers
- 23 people
- Sponsor
- Boehringer Ingelheim
Obesity
APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE
A double-blind, cross-over, placebo-controlled, proof-of-concept study using oral peptide YY3-36 solution to investigate the mechanistic role of lingual PYY in regulating appetite, energy intake and food preference in people with…
- Trial name
- APPETITE (NCT05110664)
- Testing
- PYY (3-36) Peptide, Placibo
- Volunteers
- 40 people
- Sponsor
- University College, London
Over Weight People
Shanghai Meiji Health Science and Technology Co., Ltd
Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity.
- Trial name
- NCT04651023
- Testing
- Nelumbo nucifera Leaf Extract
- Volunteers
- 95 people, healthy volunteers welcome
- Sponsor
- Shanghai Meiji Health Science and Technology Co., Ltd.
Morbid Obesity
Outpatient Treatment of Patients With Morbid Obesity - a Two-year Follow up
This study is a pilot project to investigate any effect on these markers in conjunction with lifestyle changes / conservative treatment.
- Trial name
- NCT01249209
- Testing
- lifestyle advice
- Where
- Norway
- Volunteers
- 69 people
- Sponsor
- Sykehuset Innlandet HF
Frailty, Obesity
Slow Gait Speed as an Indicator of Overweight, Dynapenic Obesity and Sarcopenic Obesity in Elderly People in the Community
The goal of this observational study is to evaluate the relationship of gait speed with dynapenic or sarcopenic obesity in community-dwelling older people.
- Conditions
- Frailty, Obesity, Sarcopenia, Sarcopenic Obesity
- Trial name
- SGSF (NCT06413030)
- Testing
- 10 Meter Walk Test
- Where
- Chile
- Volunteers
- 383 people, healthy volunteers welcome
- Sponsor
- University of Americas - Chili
Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)
Researchers are looking for a better way to help people with any known or suspected problems (except brain or spinal cord-related problems) scheduled for a "contrast-enhanced" Magnetic Resonance Imaging (MRI).
- Trial name
- Quanti OBR (NCT05915728)
- Testing
- Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine
- Where
- 85 sites in United States, Argentina and 14 more
- Volunteers
- 410 people
- Sponsor
- Bayer
Contrast Enhancement in Magnetic Resonance Imaging, Central Nervous System Pathology
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems
Researchers are looking for a better way to help people with known or suspected brain or spinal cord-related problems scheduled for a "contrast-enhanced" Magnetic Resonance Imaging (MRI).
- Trial name
- Quanti CNS (NCT05915702)
- Testing
- Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine
- Where
- 78 sites in United States, Argentina and 13 more
- Volunteers
- 321 people
- Sponsor
- Bayer
Diabetes Mellitus, Type II, Overweight or Obesity
Differences in Postprandial Glucose Changes
Following a meal, in nondiabetic individuals, blood glucose rises to peak at 1hr and returns to baseline in 2 - 3 hours. In T2DM, this peak is higher and prolonged.
- Trial name
- NCT05957224
- Testing
- Shake 1 then Shake 2, Shake 2 then Shake 1
- Volunteers
- 25 people
- Sponsor
- The University of The West Indies
Overweight, Healthy
Precision Exercise Therapeutics (PET-pilot)
The aim of this randomized cross-over study is to collect information for the design of a precision exercise therapy cohort that will predict what modality of physical activity a physically inactive individual with overweight…
- Trial name
- NCT05718089
- Testing
- Continuous aerobic exercise, High intensity interval training, Resistance training
- Where
- Denmark
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Obesity, Overweight
Effectiveness and Safety of Acupuncture for Obesity and Over-weight People
To determine the efficacy and safety of acupuncture for obesity and overweight people in China.
- Trial name
- NCT02108236
- Testing
- acupuncture
- Where
- China
- Volunteers
- 110 people
- Sponsor
- Heilongjiang University of Chinese Medicine
Pulmonary Disease, Chronic Obstructive
Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)
The purpose of this study is to evaluate the metabolic load during a single session of moderate intensity walking in water compared to walking on land (over-ground) in people with chronic obstructive pulmonary disease (COPD) who…
- Trial name
- NCT02757157
- Testing
- Water-based walking, Land-based walking
- Where
- Netherlands
- Volunteers
- 14 people
- Sponsor
- European Respiratory Society
Obesity
Antidiabetic Properties of Rose Hip
The purpose of this study is to determine whether daily intake of a drink containing rose hip powder reduces risk markers of type diabetes and cardiovascular disease.
- Trial name
- NCT01316016
- Testing
- Rose hip
- Where
- Sweden
- Volunteers
- 31 people
- Sponsor
- Lund University